Fluoxetine in Depressed AUD Adolescents: A 1-Year Follow-up Evaluation

Journal of Child and Adolescent Psychopharmacology

Volumn 14, Issue 1, 2004, Pages 33-38

  Cornelius, Jack R ^a,b   Bukstein, Oscar G ^a   Salloum, Ihsan M ^a   Kelly, Thomas M ^a   Wood, D Scott ^a   Clark, Duncan B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE;

ADOLESCENT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DRINKING BEHAVIOR; EVALUATION; FOLLOW UP; HAMILTON SCALE; HUMAN; LONG TERM CARE; PSYCHOTHERAPY; RECURRENT DISEASE; RELAPSE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYMPTOM;

ADOLESCENT; ADULT; ALCOHOL-RELATED DISORDERS; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DUAL (PSYCHIATRY); DRUG EVALUATION; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MALE; TREATMENT OUTCOME;

EID: 1942507411     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454604773840463     Document Type: Article

References (12)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington (DC), American Psychiatric Association, 1994.
2. Bukstein OG, Glancy LJ, Kaminer Y: Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J Am Acad Child Adolesc Psychiatry 31:1041-1045, 1992.
3. Clark DB, Bukstein O, Cornelius J: Alcohol use disorders in adolescents: Epidemiology, diagnosis, psychosocial interventions, and pharmacological treatment. Paediatr Drugs 4:493-502, 2002.
4. Cornelius JR, Bukstein OG, Birmaher B, Salloum IM, Lynch K, Pollock NK, Gershon S, Clark D: Fluoxetine in adolescents with major depression and an alcohol use disorder: An open-label trial. Addict Behav 26:735-739, 2001.
5. Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Perel JM, Thase ME, Black A: Fluoxetine in depressed alcoholics: A double-blind, placebo-controlled trial. Arch Gen Psychiatry 54:700-705, 1997.
6. Cornelius JR, Salloum IM, Haskett RF, Daley DC, Cornelius MD, Thase ME, Perel JM: Fluoxetine versus placebo in depressed alcoholics: A 1-year follow-up study. Addict Behav 25:307-310, 2000.
7. Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Carmody T, Mayes TL: Fluoxetine in child and adolescent depression: Acute and maintenance treatment. Depress Anxiety 7:32-39, 1998.
8. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62, 1960.
9. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
10. Martin CS, Pollock NK, Bukstein OG, Lynch KG: Inter-rater reliability of the SCID alcohol and substance use disorders section among adolescents. Drug Alcohol Depend 59:173-176, 2000.
11. Riggs PD, Mikulich SK, Coffman LM, Crowley TJ: Fluoxetine in drug-dependent delinquents with major depression: An open trial. J Child Adolesc Psychopharmacol 7:87-95, 1997.
12. Sobell LC, Sobel MB, Leo GI, Cancilla A: Reliability of a timeline method: Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict 83:393-402, 1988.